Rotigaptide

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameRotigaptide
Drug Alias Name洛替加肽rotigaptiderotigaptida罗替加肽rotigaptidum +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGap junction proteins modulators
TargetsGap junction proteins
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUkraine +[16] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG